Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence

Neuroscience and Biobehavioral Reviews

Volumn 36, Issue 2, 2012, Pages 873-888

  Gilpin, Nicholas W ^a   Roberto, Marisa ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Alcohol dependence; Cannabinoids; Central amygdala; CRF; Dynorphin; GABA; Galanin; Glutamate; Neuropeptides; Nociceptin; NPY

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; CORTICOTROPIN RELEASING FACTOR; DYNORPHIN; ENDOCANNABINOID; GALANIN; KAPPA OPIATE RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE Y; NOCICEPTIN;

4 AMINOBUTYRIC ACID RELEASE; ALCOHOLISM; BRAIN FUNCTION; CENTRAL NUCLEUS (AMYGDALA); EMOTIONALITY; GABAERGIC TRANSMISSION; HUMAN; INHIBITION (PSYCHOLOGY); NERVE CELL PLASTICITY; NEUROMODULATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SYNAPTIC TRANSMISSION;

ALCOHOLISM; AMYGDALA; ANIMALS; HUMANS; NEURONAL PLASTICITY; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS;

EID: 84856096611     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2011.11.002     Document Type: Review

References (257)

1. Aguilar-Valles A., Sánchez E., de Gortari P., Baldera I., Ramírez-Amaya V., Bermúdez-Rattoni F., Joseph-Bravo P. Analysis of the stress response in rats trained in the water-maze: differential expression of corticotropin-releasing hormone, CRHR1, glucocorticoid receptors and brain-derived neurotrophic factor in limbic regions. Neuroendocrinology 2005, 82:306-319.
2. Aguayo L.G., Peoples R.W., Yeh H.H., Yevenes G.E. GABA(A) receptors as molecular sites of ethanol action. Direct or indirect actions?. Curr. Top. Med. Chem. 2002, 2:869-885.
3. Akinshola B.E., Stewart R.R., Karvonen L.L., Taylor R.E., Liesi P. Involvement of non-NMDA receptors in the rescue of weaver cerebellar granule neurons and sensitivity to ethanol of cerebellar AMPA receptors in oocytes. Brain Res. Mol. Brain Res. 2001, 93:8-17.
4. Allen Y.S., Roberts G.W., Bloom S.R., Crow T.J., Polak J.M. Neuropeptide Y in the stria terminalis: evidence for an amygdalofugal projection. Brain Res. 1984, 321:357-362.
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Press, Washington, DC. 4th ed.
6. A receptors. Alcohol. Clin. Exp. Res. 2007, 31:1061-1070.
7. Arborelius L., Skelton K.H., Thrivikraman K.V., Plotsky P.M., Schulz D.W., Owens M.J. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat. J. Pharmacol. Exp. Ther. 2000, 294:588-597.
8. Ariwodola O.J., Weiner J.L. Ethanol potentiation of GABAergic synaptic transmission may be self-limiting: role of presynaptic GABA(B) receptors. J. Neurosci. 2004, 24:10679-10686.
9. Bajo M., Cruz M.T., Siggins G.R., Messing R., Roberto M. Protein kinase C epsilon mediation of CRF- and ethanol-induced GABA release in central amygdala. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:8410-8415.
10. Bajo, M., Madamba, S.G., Lu, X., Sharkey, L.M., Bartfai, T., Siggins, G.R. Receptor subtype-dependent galanin actions on GABAergic neurotransmission and ethanol responses in the central amygdala. Addict. Biol., EPub ahead of print, in press. doi:10.1111/j.1369-1600.2011.00360.x.
11. Barrera G., Hernandez A., Poulin J.F., Laforest S., Drolet G., Morilak D.A. Galanin-mediated anxiolytic effect in rat central amygdala is not a result of corelease from noradrenergic terminals. Synapse 2006, 59:27-40.
12. Beadles-Bohling A.S., Crabbe J.C., Wiren K.M. Elevated prodynorphin expression associated with ethanol withdrawal convulsions. Neurochem. Int. 2000, 37:463-472.
13. Bing O., Möller C., Engel J.A., Söderpalm B., Heilig M. Anxiolytic-like action of centrally administered galanin. Neurosci. Lett. 1993, 164:17-20.
14. Blednov Y.A., Harris R.A. Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions. Int. J. Neuropsychopharmacol. 2008, 11:775-793.
15. Borghese C.M., Harris R.A. Studies of ethanol actions on recombinant δ-containing γ-aminobutyric acid type A receptors yield contradictory results. Alcohol 2007, 41:155-162.
16. Boyle A.E., Segal R., Smith B.R., Amit Z. Bidirectional effects of GABAergic agonists and antagonists on maintenance of voluntary ethanol intake in rats. Pharmacol. Biochem. Behav. 1993, 46:179-182.
17. Branchek T.A., Smith K.E., Gerald C., Walker M.W. Galanin receptor subtypes. Trends Pharmacol. Sci. 2000, 21:109-117.
18. Breese G.R., Criswell H.E., Carta M., Dodson P.D., Hanchar H.J., Khisti R.T., Mameli M., Ming Z., Morrow A.L., Olsen R.W., et al. Basis of the gabamimetic profile of ethanol. Alcohol. Clin. Exp. Res. 2006, 30:731-744.
19. Bruchas M.R., Land B.B., Chavkin C. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res. 2010, 1314:44-55.
20. Butler P.D., Weiss J.M., Stout J.C., Nemeroff C.B. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J. Neurosci. 1990, 10:176-183.
21. Carpenter-Hyland E.P., Woodward J.J., Chandler L.J. Chronic ethanol induces synaptic but not extrasynaptic targeting of NMDA receptors. J. Neurosci. 2004, 24:7859-7868.
22. Cassell M.D., Freedman L.J., Shi C. The intrinsic organization of the central extended amygdala. Ann. N. Y. Acad. Sci. 1999, 877:217-241.
23. Cassell M.D., Gray T.S., Kiss J.Z. Neuronal architecture in the rat central nucleus of the amygdala: a cytological, hodological, and immunocytochemical study. J. Comp. Neurol. 1986, 246:478-499.
24. Cebers G., Cebere A., Wagner A., Liljequist S. Prolonged inhibition of glutamate reuptake down-regulates NMDA receptor functions in cultured cerebellar granule cells. J. Neurochem. 1999, 72:2181-2190.
25. Chen X., DiMaggio D.A., Han S.P., Westfall T.C. Autoreceptor-induced inhibition of neuropeptide Y release from PC-12 cells is mediated by Y2 receptors. J. Am. Physiol. 1997, 273:H1737-H1744.
26. Chu K., Koob G.F., Cole M., Zorrilla E.P., Roberts A.J. Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacol. Biochem. Behav. 2007, 86:813-821.
27. Ciccocioppo R., Biondini M., Antonelli L., Wichmann J., Jenck F., Massi M. Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198. Psychopharmacology 2002, 161:113-119.
28. Ciccocioppo R., Cippitelli A., Economidou D., Fedeli A., Massi M. Nociceptin/orphanin FQ acts as a functional antagonist of corticotropin-releasing factor to inhibit its anorectic effect. Physiol. Behav. 2004, 82:63-68.
29. Ciccocioppo R., Economidou D., Cippitelli A., Cucculelli M., Ubaldi M., Soverchia L., Lourdusamy A., Massi M. Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism. Addict. Biol. 2006, 11:339-355.
30. Ciccocioppo R., Economidou D., Fedeli A., Angeletti S., Weiss F., Heilig M., et al. Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats. Psychopharmacology 2004, 172:170-178.
31. Ciccocioppo R., Economidou D., Rimondini R., Sommer W., Massi M., Heilig M. Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system. Biol. Psychiatry 2007, 61:4-12.
32. Ciccocioppo R., Fedeli A., Economidou D., Policani F., Weiss F., Massi M. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. J. Neurosci. 2003, 23:9445-9451.
33. Ciccocioppo R., Martin-Fardon R., Weiss F., Massi M. Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats. Neuroreport 2001, 12:1145-1149.
34. Ciccocioppo R., Panocka I., Polidori C., Regoli D., Massi M. Effect of nociceptin on alcohol intake in alcohol-preferring rats. Psychopharmacology 1999, 141:220-224.
35. Cippitelli A., Damadzic R., Hansson A.C., Singley E., Sommer W.H., Eskay R., et al. Neuropeptide Y (NPY) suppresses yohimbine-induced reinstatement of alcohol seeking. Psychopharmacology 2010, 208:417-426.
36. Clarke T.K., Treutlein J., Zimmermann U.S., Kiefer F., Skowronek M.H., Rietschel M., Mann K., Schumann G. HPA-axis activity in alcoholism: examples for a gene-environment interaction. Addict. Biol. 2008, 13:1-14.
37. Colombo G., Grant K.A. NMDA receptor complex antagonists have ethanol-like discriminative stimulus effects. Ann. N. Y. Acad. Sci. 1992, 654:421-423.
38. Colombo G., Serra S., Brunetti G., Gomez R., Melis S., Vacca G., et al. Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology 2002, 159:181-187.
39. Colombo G., Serra S., Vacca G., Carai M.A.M., Gessa G.L. Endocannabinoid system and alcohol addiction: pharmacological studies. Pharmacol. Biochem. Behav. 2005, 81:369-380.
40. Cooper B.R., Viik K., Ferris R.M., White H.L. Antagonism of the enhanced susceptibility to audiogenic seizures during alcohol withdrawal in the rat by gamma-aminobutyric acid (GABA) and " GABA-mimetic" agents. J. Pharmacol. Exp. Ther. 1979, 209:396-403.
41. Cowen M.S., Chen F., Lawrence A.J. Neuropeptides: implications for alcoholism. J. Neurochem. 2004, 89:273-285.
42. Criswell H.E., Breese G.R. A conceptualization of integrated actions of ethanol contributing to its GABAmimetic profile: a commentary. Neuropsychopharmacology 2005, 30:1407-1425.
43. Cruz M.T., Bajo M., Magnoli E.M., Tabakoff B., Siggins G.R., Roberto M. Type 7 adenylyl cyclase is involved in the ethanol and CRF sensitivity of GABAergic synapses in mouse central amygdala. Front. Neurosci. 2011, 4:1-7.
44. Cruz M.T., Herman M.A., Kallupi M., Roberto M. Nociceptin/orphanin FQ Blockade of CRF-induced GABA Release in Central Amygdala is Enhanced after Chronic Ethanol Exposure. Biol. Psychiat., in press.
45. Dahchour A., De Witte P. Effect of repeated ethanol withdrawal on glutamate microdialysate in the hippocampus. Alcohol. Clin. Exp. Res. 1999, 23:1698-1703.
46. Dahchour A., De Witte P. Excitatory and inhibitory amino acid changes during repeated episodes of ethanol withdrawal: an in vivo microdialysis study. Eur. J. Pharmacol. 2003, 459:171-178.
47. Davis M. Are different parts of the extended amygdala involved in fear versus anxiety?. Biol. Psychiatry 1998, 44:1239-1247.
48. Davis M., Walker D.L., Miles L., Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 2010, 35:105-135.
49. De Quidt M.E., Emson P.C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system-II. Immunohistochemcial analysis. Neuroscience 1986, 18:545-618.
50. De Souza E.B., Perrin M.H., Insel T.R., Rivier J., Vale W.W., Kuhar M.J. Corticotropin-releasing factor receptors in rat forebrain: autoradiographic identification. Science 1984, 224:1449-1451.
51. 3H]zolpidem binding in rat brain. Alcohol. Clin. Exp. Res. 1995, 19:910-914.
52. Dildy-Mayfield J.E., Harris R.A. Comparison of ethanol sensitivity of rat brain kainate, dl-alpha-amino-3-hydroxy-5-methyl-4-isoxalone proprionic acid and N-methyl-d-aspartate receptors expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 1992, 262:487-494.
53. Dildy J.E., Leslie S.W. Ethanol inhibits NMDA-induced increases in free intracellular Ca2+ in dissociated brain cells. Brain Res. 1989, 499:383-387.
54. Dong H.-W., Petrovich G.D., Swanson L.W. Organization of projections from the juxtacapsular nucleus of the BST: a PHAL study in the rat. Brain Res. 2000, 859:1-14.
55. Dumont Y., Fournier A., St-Pierre S., Schwartz T.W., Quirion R. Differential distribution of Y1 and Y2 receptors in the rat brain. Eur. J. Pharmacol. 1990, 191:501-503.
56. Eckardt M.J., File S.E., Gessa G.L., Grant K.A., Guerri C., Hoffman P.L., Kalant H., Koob G.F., Li T.K., Tabakoff B. Effects of moderate alcohol consumption on the central nervous system. Alcohol. Clin. Exp. Res. 1998, 22:998-1040.
57. Economidou D., Hansson A.C., Weiss F., Terasmaa A., Sommer W.H., Cippitelli A., et al. Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat. Biol. Psychiatry 2008, 64:211-218.
58. Edenberg H.J., Wang J., Tian H., Pochareddy S., Xuei X., Wetherill L., et al. A regulatory variation in OPRK1, the gene encoding the κ-opioid receptor, is associated with alcohol dependence. Hum. Mol. Genet. 2008, 17:1783-1789.
59. Ehrlich I., Humeau Y., Grenier F., Ciocchi S., Herry C., Lüthi A. Amygdala inhibitory circuits and the control of fear memory. Neuron 2009, 62:757-771.
60. Eiler W.J., June H.L. Blockade of GABA(A) receptors within the extended amygdala attenuates D(2) regulation of alcohol-motivated behaviors in the ventral tegmental area of alcohol-preferring (P) rats. Neuropharmacology 2007, 52:1570-1579.
61. Eva C., Oberto A., Mele P., Serra M., Biggio G. Role of brain neuroactive steroids in the functional interplay between the GABAA and the NPY-Y1 receptor mediated signals in the amygdala. Pharmacol. Biochem. Behav. 2006, 84:568-580.
62. A receptors in basolateral amygdala. J. Pharmacol. Exp. Ther. 2004, 311:1071-1079.
63. Floyd D.W., Jung K.Y., McCool B.A. Chronic ethanol ingestion facilitates N-methyl-d-aspartate receptor function and expression in rat lateral/basolateral amygdala neurons. J. Pharmacol. Exp. Ther. 2003, 307:1020-1029.
64. Francesconi W., Berton F., Koob G.F., Sanna P.P. Intrinsic neuronal plasticity in the juxtacapsular nucleus of the bed nuclei of the stria terminalis (jcBNST). Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1347-1355.
65. Frye G.D., McCown T.J., Breese G.R. Characterization of susceptibility to audiogenic seizures in ethanol-dependent rats after microinjection of gamma-aminobutyric acid (GABA) agonists into the inferior colliculus, substantia nigra or medial septum. J. Pharmacol. Exp. Ther. 1983, 227:663-670.
66. Funk C.K., O'Dell L.E., Crawford E.F., Koob G.F. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J. Neurosci. 2006, 26:11324-11332.
67. Funk C.K., Zorrilla E.P., Lee M.-J., Rice K.C., Koob G.F. Corticotropin-releasing factor-1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol. Psychiatry 2007, 61:78-86.
68. Gehlert D.R., Cippitelli A., Thorsell A., Lê A.D., Hipskind P.A., Hamdouchi C., et al. 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J. Neurosci. 2007, 27:2718-2726.
69. Gilpin N.W., Misra K., Herman M.A., Cruz M.T., Koob G.F., Roberto M. Neuropeptide Y opposes alcohol effects on gamma-aminobutyric acid release in amygdala and blocks the transition to alcohol dependence. Biol. Psychiatry 2011, 69:1091-1099.
70. Gilpin N.W., Misra K., Koob G.F. Neuropeptide Y in the central nucleus of the amygdala suppresses dependence-induced decreases in alcohol drinking. Pharmacol. Biochem. Behav. 2008, 90:475-480.
71. Gilpin N.W., Smith A.D., Cole M., Weiss F., Koob G.F., Richardson H.N. Operant behavior and alcohol levels in blood and brain of alcohol-dependent rats. Alcohol. Clin. Exp. Res. 2009, 33:2113-2123.
72. Gilpin N.W., Stewart R.B., Badia-Elder N.E. Neuropeptide Y administration into the amygdala suppresses ethanol drinking in alcohol-preferring (P) rats following multiple deprivations. Pharmacol. Biochem. Behav. 2008, 90:470-474.
73. Gilpin N.W., Stewart R.B., Elder R.L., Kho Y., Murphy J.M., Li T.K., Badia-Elder N.E. Sedative and motor-impairing effects of neuropeptide Y and ethanol in selectively bred P and NP rats. Pharmacol. Biochem. Behav. 2004, 78:65-73.
74. Gilpin N.W., Stewart R.B., Murphy J.M., Badia-Elder N.E. Effects of neuropeptide Y in the paraventricular nucleus of the hypothalamus on ethanol intake in HAD1 and LAD1 rats depend on availability of food. Alcohol. Clin. Exp. Res. 2004, 28:1492-1498.
75. Grahame N.J., Li T.K., Lumeng L. Limited access alcohol drinking in high- and low-alcohol preferring selected lines of mice. Alcohol. Clin. Exp. Res. 1999, 23:1015-1022.
76. Greber S., Schwarzer C., Sperk G. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol. 1994, 113:737-740.
77. Grobin A.C., Matthews D.B., Devaud L.L., Morrow A.L. The role of GABA(A) receptors in the acute and chronic effects of ethanol. Psychopharmacology 1998, 139:2-19.
78. A receptor expression: potential mechanisms. Neurochem. Int. 2000, 37:453-461.
79. Grover C.A., Wallace K.A., Lindberg S.A., Frye G.D. Ethanol inhibition of NMDA currents in acutely dissociated medial septum/diagonal band neurons from ethanol dependent rats. Brain Res. 1998, 782:43-52.
80. Gulya K., Grant K.A., Valverius P., Hoffman P.L., Tabakoff B. Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res. 1991, 547:129-134.
81. Gustafson E.L., Smith K.E., Durkin M.M., Walker M.W., Gerald C., Weinshank R., Branchek T.A. Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system. Mol. Brain Res. 1997, 46:223-235.
82. Han T.M., De Vries G.J. Neurogenesis of galanin cells in the bed nucleus of the stria terminalis and centromedial amygdala in rats: a model for sexual differentiation of neuronal phenotype. J. Neurobiol. 1999, 38:491-498.
83. Hansson A.C., Cippitelli A., Sommer W.H., Fedeli A., Bjork K., Soverchia L., Terasmaa A., Massi M., Heilig M., Ciccocioppo R. Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:15236-15241.
84. Hasue R.H., Shammah-Lagnado S.J. Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: a combined retrograde tracing and immunohistochemical study in the rat. J. Comp. Neurol. 2002, 454:15-33.
85. Heilig M., Egli M., Crabbe J.C., Becker H.C. Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?. Addict. Biol. 2010, 15:169-184.
86. Heilig M., Koob G.F., Ekman R., Britton K.T. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci. 1994, 17:80-85.
87. Heilig M., McLeod S., Brot M., Heinrichs S.C., Menzaghi F., Koob G.F., Britton K.T. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 1993, 8:357-363.
88. Heilig M., McLeod S., Koob G.K., Britton K.T. Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test. Regul. Pept. 1992, 41:61-69.
89. Heilig M., Murison R. Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat. Regul. Pept. 1987, 19:221-231.
90. Heilig M., Söderpalm B., Engel J.A., Widerlöv E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology 1989, 98:524-529.
91. Heimer L., Alheid G. Piecing together the puzzle of basal forebrain anatomy. The Basal Forebrain: Anatomy To Function (series title: Advances in Experimental Medicine and Biology, vol. 295) 1991, 1-42. Plenum Press, New York. T.C. Napier, P.W. Kalivas, I. Hanin (Eds.).
92. A subunit mRNAs in prefrontal fields of cynomolgus monkeys. Alcohol. Clin. Exp. Res. 2006, 30:1978-1985.
93. Hodge C.W., Chappelle A.M., Samson H.H. GABAergic transmission in the nucleus accumbens is involved in the termination of ethanol self-administration in rats. Alcohol. Clin. Exp. Res. 1995, 19:1486-1493.
94. Hokfelt T., Xu Z.Q., Shi T.J., Holmberg K., Zhang X. Galanin in ascending systems. Focus on coexistence with 5-hydroxytryptamine and noradrenaline. Ann. N. Y. Acad. Sci. 1998, 863:252-263.
95. Hoffman P.L., Rabe C.S., Moses F., Tabakoff B. N-methyl-d-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. J. Neurochem. 1989, 52:1937-1940.
96. Huang M.M., Overstreet D.H., Knapp D.J., Angel R., Wills T.A., Navarro M., Rivier J., Vale W., Breese G.R. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization. J. Pharmacol. Exp. Ther. 2010, 332:298-307.
97. Hungund B.L., Szakall I., Adam A., Basavarajappa B.S., Vadasz C. Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J. Neurochem. 2003, 84:698-704.
98. Hyytia P., Koob G.F. GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur. J. Pharmacol. 1995, 283:151-159.
99. Jenck F., Moreau J.L., Martin J.R., Kilpatrick G.J., Reinscheid R.K., Monsma F.J., Nothacker H.P., Civelli O. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:14854-14858.
100. Jenck F., Wichmann J., Dautzenberg F.M., Moreau J.L., Ouagazzal A.M., Martin J.R., Lundstrom K., Cesura A.M., Poli S.M., Roever S., Kolczewski S., Adam G., Kilpatrick G. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:4938-4943.
101. Kalivas P.W. The glutamate homeostasis hypothesis of addiction. Nat. Rev. Neurosci. 2009, 10:561-572.
102. Kash T.L., Baucum A.J., Conrad K.L., Colbran R.J., Winder D.G. Alcohol exposure alters NMDAR function in the bed nucleus of the stria terminalis. Neuropsychopharmacology 2009, 34:2420-2429.
103. Kash T.L., Nobis W.P., Matthews R.T., Winder D.G. Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process. J. Neurosci. 2008, 28:13856-13865.
104. Kash T.L., Winder D.G. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 2006, 51:1013-1022.
105. Kawahara Y., Hesselink M.B., van Scharrenburg G., Westerink B.H. Tonic inhibition by orphanin FQ/nociceptin of noradrenaline neurotransmission in the amygdala. Eur. J. Pharmacol. 2004, 485:197-200.
106. Kelm M.K., Criswell H.E., Breese G.R. Ethanol-enhanced GABA release: a focus on G protein-coupled receptors. Brain Res. Rev. 2011, 65:113-123.
107. Kelm M.K., Weinberg R.J., Criswell H.E., Breese G.R. The PLC/IP 3 R/PKC pathway is required for ethanol-enhanced GABA release. Neuropharmacology 2010, 58:1179-1186.
108. Khoshbouei H., Cecchi M., Dove S., Javors M., Morilak D.A. Behavioral reactivity to stress: amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala. Pharmacol. Biochem. Behav. 2002, 71:407-417.
109. Kiefer F., Wiedemann K. Neuroendocrine pathways of addictive behaviour. Addict. Biol. 2004, 9:205-212.
110. Kliethermes C.L. Anxiety-like behaviors following chronic ethanol exposure. Neurosci. Biobehav. Rev. 2005, 28:837-850.
111. Koob G.F. Alcoholism: allostasis and beyond. Alcohol. Clin. Exp. Res. 2003, 27:232-243.
112. Koob A role for brain stress systems in addiction. Neuron 2008, 59:11-34.
113. Koob G.F. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 2009, 56(Suppl. 1):18-31.
114. Koob G.F., Swerdlow N., Seeligson M., Eaves M., Sutton R., Rivier J., Vale W. Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation. Neuroendocrinology 1984, 39:459-464.
115. Koob G.F., Thatcher-Britton K. Stimulant and anxiogenic effects of corticotropin releasing factor. Prog. Clin. Biol. Res. 1985, 192:499-506.
116. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
117. A receptor subtypes? The current evidence is ambiguous. Alcohol 2007, 41:163-176.
118. Köster A., Montkowski A., Schulz S., Stübe E.M., Knaudt K., Jenck F., Moreau J.L., Nothacker H.P., Civelli O., Reinscheid R.K. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:10444-10449.
119. Kovacs K.M., Szakall I., O'Brien D., Wang R., Vinod K.Y., Saito M., Simonin F., Kieffer B.L., Vadasz C. Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. Alcohol. Clin. Exp. Res. 2005, 29:730-738.
120. Krahn D.D., Gosnell B.A., Levine A.S., Morley J.E. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res. 1988, 443:63-69.
121. Krettek J.E., Price J.L. Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat. J. Comp. Neurol. 1978, 178:225-254.
122. Kumar S., Fleming R.L., Morrow A.L. Ethanol regulation of gamma-aminobutyric acid A receptors: genomic and nongenomic mechanisms. Pharmacol. Ther. 2004, 101:211-226.
123. Kumar S., Porcu P., Werner D.F., Matthews D.B., Diaz-Granados J.L., Helfand R.S., Morrow A.L. The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress. Psychopharmacology 2009, 205:529-564.
124. Kuzmin A., Bazov I., Sheedy D., Garrick T., Harper C., Bakalkin G Expression of pronociceptin and its receptor is downregulated in the brain of human alcoholics. Brain Res. 2009, 1305(Suppl.):S80-S85.
125. Kuzmin A., Kreek M.J., Bakalkin G., Liljequist S. The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking. Neuropsychopharmacology 2007, 32:902-910.
126. Kuzmin A., Sandin J., Terenius L., Ogren S.O. Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone. J. Pharmacol. Exp. Ther. 2003, 304:310-318.
127. Läck A.K., Diaz M.R., Chappell A., DuBois D.W., McCool B.A. Chronic ethanol and withdrawal differentially modulate pre- and postsynaptic function at glutamatergic synapses in rat basolateral amygdala. J. Neurophysiol. 2007, 98:3185-3196.
128. Läck A.K., Ariwodola O.J., Chappell A.M., Weiner J.L., McCool B.A. Ethanol inhibition of kainate receptor-mediated excitatory neurotransmission in the rat basolateral nucleus of the amygdala. Neuropharmacology 2008, 55:661-668.
129. Läck A.K., Floyd D.W., McCool B.A. Chronic ethanol ingestion modulates proanxiety factors expressed in rat central amygdala. Alcohol 2005, 36:83-90.
130. Larriva-Sahd J. Juxtacapsular nucleus of the stria terminalis of the adult rat: extrinsic inputs, cell types, and neuronal modules: a combined golgi and electron microscopic study. J. Comp. Neurol. 2004, 475:220-237.
131. Lam M.P., Marinelli P.W., Bai L., Gianoulakis C. Effects of acute ethanol on opioid peptide release in the central amygdala: an in vivo microdialysis study. Psychopharmacology 2008, 201:261-271.
132. Land B.B., Bruchas M.R., Lemos J.C., Xu M., Melief E.J., Chavkin C. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J. Neurosci. 2008, 28:407-414.
133. Lee Y., Fitz S., Johnson P.L., Shekhar A. Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety. Neuropsychopharmacology 2008, 33:2586-2594.
134. Lee E.H., Tsai M.J. The hippocampus and amygdala mediate the locomotor stimulating effects of corticotropin-releasing factor in mice. Behav. Neural Biol. 1989, 51:412-423.
135. Leenders A.G., Sheng Z.H. Modulation of neurotransmitter release by the second messenger-activated protein kinases: implications for presynaptic plasticity. Pharmacol. Ther. 2005, 105:69-84.
136. Levine A.S., Morley J.E. Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides 1984, 5:1025-1029.
137. Levine A.S., Rogers B., Kneip J., Grace M., Morley J.E. Effect of centrally administered corticotropin releasing factor (CRF) on multiple feeding paradigms. Neuropharmacology 1983, 22:337-339.
138. Liang K.C., Melia K.R., Campeau S., Falls W.A., Miserendino M.J., Davis M. Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex. J. Neurosci. 1992, 12:2313-2320.
139. Lieber C., DeCarli L. Ethanol dependence and tolerance: a nutritionally controlled experimental model in the rat. Res. Commun. Chem. Pathol. Pharmacol. 1973, 6:983-991.
140. Lima-Landman M.T., Albuquerque E.X. Ethanol potentiates and blocks NMDA-activated single-channel currents in rat hippocampal pyramidal cells. FEBS Lett. 1989, 247:61-67.
141. Littleton J.M. Acamprosate in alcohol dependence: implications of a unique mechanism of action. J. Addict. Med. 2007, 1:115-125.
142. Lovinger D.M., Homanics G.E. Tonic for what ails us? High-affinity GABAA receptors and alcohol. Alcohol 2007, 41:139-143.
143. Lovinger, D.M., Roberto, M. Synaptic effects induced by alcohol. Behavioural Neurobiology of Alcohol Addiction. Current Topics in Behavioral Neurosciences. In: Spanagel, R., Sommerm, W.H. (Eds.), Springer-Verlag, Berlin, Heidelberg, in press.
144. Lovinger D.M., White G., Weight F.F. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 1989, 243:1721-1724.
145. Lovinger D.M., White G., Weight F.F. NMDA receptor-mediated synaptic excitation selectively inhibited by ethanol in hippocampal slice from adult rat. J. Neurosci. 1990, 10:1372-1379.
146. Lowery E.G., Sparrow A.M., Breese G.R., Knapp D.J., Thiele T.E. The CRF-1 receptor antagonist, CP-154,526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice. Alcohol. Clin. Exp. Res. 2008, 32:240-248.
147. Mann K., Kiefer F., Spanagel R., Littleton J. Acamprosate: recent findings and future research directions. Alcohol. Clin. Exp. Res. 2008, 32:1105-1110.
148. Mansour A., Burke S., Pavlic R.J., Akil H., Watson S.J. Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary. Neuroscience 1996, 71:671-690.
149. Marchant N.J., Densmore V.S., Osborne P.B. Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division. J. Comp. Neurol. 2007, 504:702-715.
150. Marinelli P.W., Funk D., Juzytsch W., Harding S., Rice K.C., Shaham Y., Le A.D. The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology 2007, 195:345-355.
151. Marinelli P.W., Lam M., Bai L., Quirion R., Gianoulakis C. A microdialysis profile of dynorphin A(1-8) release in the rat nucleus accumbens following alcohol administration. Alcohol. Clin. Exp. Res. 2006, 30:982-990.
152. Martz A., Deitrich R.A., Harris R.A. Behavioral evidence for the involvement of gamma-aminobutyric acid in the actions of ethanol. Eur. J. Pharmacol. 1983, 89:53-62.
153. Martin-Fardon R., Ciccocioppo R., Massi M., Weiss F. Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats. Neuroreport 2000, 11:1939-1943.
154. McCool B.A., Christian D.T., Diaz M.R., Läck A.K. Glutamate plasticity in the drunken amygdala: the making of an anxious synapse. Int. Rev. Neurobiol. 2010, 91:205-233.
155. McCown T.J., Frye G.D., Breese G.R. Evidence for site specific ethanol actions in the CNS. Alcohol Drug Res. 1985, 6:423-429.
156. Melendez R.I., Hicks M.P., Cagle S.S., Kalivas P.W. Ethanol exposure decreases glutamate uptake in the nucleus accumbens. Alcohol. Clin. Exp. Res. 2005, 29:326-333.
157. Merlo-Pich E., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G., Weiss F. Increase of extracellular corticotrophin-releasing factor-like immunoreactivity levels in the amygdale of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 1995, 15:5439-5447.
158. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995, 377:532-535.
159. Migita K., Loewy A.D., Ramabhadran T.V., Krause J.E., Waters S.M. Immunohistochemical localization of the neuropeptide Y Y1 receptor in rat central nervous system. Brain Res. 2001, 889:23-37.
160. Miller M.A., Kolb P.E., Raskind M.A. Extra-hypothalamic vasopressin neurons coexpress galanin messenger RNA as shown by double in situ hybridization histochemistry. J. Comp. Neurol. 1993, 329:378-384.
161. Miyakawa T., Yagi T., Kitazawa H., Yasuda M., Kawai N., Tsuboi K., Niki H. Fyn-kinase as a determinant of ethanol sensitivity: relation to NMDA-receptor function. Science 1997, 278:698-701.
162. Moller C., Sommer W., Thorsell A., Heilig M. Anxiogenic-like action of galanin after intra-amygdala administration in the rat. Neuropsychopharmacology 1999, 21:507-512.
163. Morrisett R.A., Swartzwelder H.S. Attenuation of hippocampal long-term potentiation by ethanol: a patch-clamp analysis of glutamatergic and GABAergic mechanisms. J. Neurosci. 1993, 13:2264-2272.
164. Morrow A.L., Herbert J.S., Montpied P. Differential effects of chronic ethanol administration on GABA(A) receptor alpha1 and alpha6 subunit mRNA levels in rat cerebellum. Mol. Cell. Neurosci. 1992, 3:251-258.
165. Moykkynen T., Korpi E.R., Lovinger D.M. Ethanol inhibits alpha-amino-3-hydyroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor function in central nervous system neurons by stabilizing desensitization. J. Pharmacol. Exp. Ther. 2003, 306:546-555.
166. Muller M., Zimmermann S., Sillaber I., Hagemeyer T.P., Deussing J.M., Timpl P., et al. Limbic corticotrophin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat. Neurosci. 2003, 6:1100-1107.
167. Murphy J.M., Stewart R.B., Bell R.L., Badia-Elder N.E., Carr L.G., McBride W.J., Lumeng L., Li T.K. Phenotypic and genotypic characterization of the Indiana University rat lines selectively bred for high and low alcohol preference. Behav. Genet. 2002, 32:363-388.
168. Naveilhan P., Canals J.M., Valjakka A., Vartiainen J., Arenas E., Ernfors P. Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism. Eur. J. Neurosci. 2001, 13:2241-2246.
169. Neal C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Watson S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 1999, 406:503-547.
170. Nguyen P.V., Abel T., Kandel E.R., Bourtchouladze R. Strain-dependent differences in LTP and hippocampus-dependent memory in inbred mice. Learn. Mem. 2000, 7:170-179.
171. Nie Z., Madamba S.G., Siggins G.R. Ethanol enhances gamma-aminobutyric acid responses in a subpopulation of nucleus accumbens neurons: role of metabotropic glutamate receptors. J. Pharmacol. Exp. Ther. 2000, 293:654-661.
172. Nie Z., Schweitzer P., Roberts A.J., Madamba S.G., Moore S.D., Siggins G.R. Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science 2004, 303:1512-1514.
173. Obara I., Bell R.L., Goulding S.P., Reyes C.M., Larson L.A., Ary A.W., Truitt W.A., Szumlinski K.K. Differential effects of chronic ethanol consumption and withdrawal on homer/glutamate receptor expression in subregions of the accumbens and amygdala of P rats. Alcohol. Clin. Exp. Res. 2009, 33:1924-1934.
174. Olive M.F., Koenig H.N., Nannini M.A., Hodge C.W. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol. Biochem. Behav. 2002, 72:213-220.
175. Ouagazzal A.M., Moreau J.L., Pauly-Evers M., Jenck F. Impact of environmental housing conditions on the emotional responses of mice deficient for nociceptin/orphanin FQ peptide precursor gene. Behav. Brain Res. 2003, 144:111-117.
176. Palkovits M. Stress-induced expression of co-localized neuropeptides in hypothalamic and amygdaloid neurons. Eur. J. Pharmacol. 2000, 405:161-166.
177. Pandey S.C., Ugale R., Zhang H., Tang L., Prakash A. Brain chromatin remodeling: a novel mechanism of alcoholism. J. Neurosci. 2008, 28:3729-3737.
178. Pandey S.C., Zhang H., Roy A., Xu T. Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J. Clin. Invest. 2005, 115:2762-2773.
179. Pape H.-C., Pare D. Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol. Rev. 2010, 90:419-463.
180. Paré D., Quirk G.J., Ledoux J.E. New vistas on amygdala networks in conditioned fear. J. Neurophysiol. 2004, 92:1-9.
181. Patel S., Cravatt B.F., Hillard C.J. Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala. Neuropsychopharmacology 2005, 30:497-507.
182. Phelps E.A., LeDoux J.E. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005, 48:175-187.
183. Pitkänen A. Connectivity of the rat amygdaloid complex. The Amygdala 2000, Oxford University Press. J.P. Aggleton (Ed.).
184. Primeaux S.D., Wilson S.P., Bray G.A., York D.A., Wilson M.A. Overexpression of neuropeptide Y in the central nucleus of the amygdala decreases ethanol self administration in " anxious" rats. Alcohol. Clin. Exp. Res. 2006, 30:791-801.
185. Pulvirenti L., Diana M. Drug dependence as a disorder of neural plasticity: focus on dopamine and glutamate. Rev. Neurosci. 2001, 12:141-158.
186. Qi Z.H., Song M., Wallace M.J., Wang D., Newton P.M., McMahon T. Protein kinase Ce{open} regulates γ-aminobutyrate type A receptor sensitivity to ethanol and benzodiazepines through phosphorylation of γ2 subunits. J. Biol. Chem. 2007, 282:33052-33063.
187. Quirk G.J., Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 2008, 33(January):56-72.
188. Rassnick S., D'Amico E., Riley E., Koob G.F. GABA antagonist and benzodiazepine partial inverse agonist reduce motivated responding for ethanol. Alcohol. Clin. Exp. Res. 1993, 17:124-130.
189. Rainnie D.G., Bergeron R., Sajdyk T.J., Patil M., Gehlert D.R., Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J. Neurosci. 2004, 24:3471-3479.
190. Rassnick S., Heinrichs S.C., Britton K.T., Koob G.F. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 1993, 605:25-32.
191. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 1995, 270:792-794.
192. Richardson H.N., Lee S.Y., O'Dell L.E., Koob G.F., Rivier C.L. Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur. J. Neurosci. 2008, 28:1641-1653.
193. Richardson H.N., Fekete E.M., Zhao Y., Funk C.K., Zorrilla E.P., Koob G.F. A novel small molecule antagonist of the corticotropin-releasing factor type 1 receptor (CRF1) is a potent anxiolytic and reduces excessive alcohol intake in dependent male rats. Pharmacol. Biochem. Behav. 2008, 88:497-510.
194. Ridge J.P., Ho A.M., Innes D.J., Dodd P.R. The expression of NMDA receptor subunit mRNA in human chronic alcoholics. Ann. N. Y. Acad. Sci. 2008, 1139:10-19.
195. Roberto M., Bajo M., Crawford E., Madamba S.G., Siggins G.R. Chronic ethanol exposure and protracted abstinence alter NMDA receptors in central amygdala. Neuropsychopharmacology 2006, 31:988-996.
196. Roberto M., Cruz M., Bajo M., Siggins G.R., Parsons L.H., Schweitzer P. The endocannabinoid system tonically regulates inhibitory transmission and depresses the effect of ethanol in central amygdala. Neuropsychopharmacology 2010, 35:1962-1972.
197. Roberto M., Cruz M.T., Gilpin N.W., Sabino V., Schweitzer P., Bajo M., et al. Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence. Biol. Psychiatry 2010, 67:831-839.
198. Roberto M., Gilpin N.W., O'Dell L.E., Cruz M.T., Morse A.C., Siggins G.R., Koob G.F. Cellular and behavioral interactions of gabapentin with alcohol dependence. J. Neurosci. 2008, 28:5762-5771.
199. Roberto M., Madamba S.G., Moore S.D., Tallent M.K., Siggins G.R. Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:2053-2058.
200. Roberto M., Madamba S.G., Stouffer D.G., Parsons L.H., Siggins G.R. Increased GABA release in the central amygdala of ethanol-dependent rats. J. Neurosci. 2004, 24:10159-10166.
201. Roberto M., Schweitzer P., Madamba S.G., Stouffer D.G., Parsons L.H., Siggins G.R. Acute and chronic ethanol alter glutamatergic transmission in rat central amygdala: an in vitro and in vivo analysis. J. Neurosci. 2004, 24:1594-1603.
202. Roberto M., Siggins G.R. Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9715-9720.
203. Roberto M., Schweitzer P., Madamba S.G., Nie Z., Siggins G.R. Ethanol-CRF interactions at GABAergic synapses in rat central amygdala. Alcohol Clin. Exp. Res. 2005, (Suppl. 29):26.
204. Roberts A.J., Cole M., Koob G.F. Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol. Clin. Exp. Res. 1996, 20:1289-1298.
205. Rodi D., Zucchini S., Simonato M., Cifani C., Massi M., Polidori C. Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin-releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis. Psychopharmacology 2008, 196:523-531.
206. Rogers J., Wiener S.G., Bloom F.E. Long-term ethanol administration methods for rats: advatnages of inhalation over intubation or liquid diets. Behav. Neural Biol. 1979, 27:466-486.
207. Rossetti Z.L., Carboni S. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur. J. Pharmacol. 1995, 283:177-183.
208. Roy A., Pandey S.C. The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. Alcohol. Clin. Exp. Res. 2002, 26:796-803.
209. Sajdyk T.J., Schober D.A., Gehlert D.R. Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats. Neuropharmacology 2002, 43:1165-1172.
210. Sajdyk T.J., Schober D.A., Gehlert D.R., Shekhar A. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav. Brain Res. 1999, 100:207-215.
211. Sajdyk T.J., Vandergriff M.G., Gehlert D.R. Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur. J. Pharmacol. 1999, 368:143-147.
212. Sakanaka M., Shibasaki T., Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res. 1986, 382:213-238.
213. Sajdyk T.J., Shekhar A., Gehlert D.R. Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides 2004, 38:225-234.
214. Sanchis-Segura C., Borchardt T., Vengeliene V., Zghoul T., Bachteler D., Gass P., Sprengel R., Spanagel R. Involvement of the AMPA receptor GluR-C subunit in alcohol-seeking behavior and relapse. J. Neurosci. 2006, 26:1231-1238.
215. Schroeder J.P., Olive F., Koenig H., Hodge C.W. Intra-Amygdala Infusion of the NPY Y1 Receptor Antagonist BIBP 3226 Attenuates Operant Ethanol Self-Administration. Alcohol. Clin. Exp. Res. 2003, 27:1884-1891.
216. Sharkey L.M., Madamba S.G., Siggins G.R., Bartfai T. Galanin alters GABAergic neurotransmission in the dorsal raphe nucleus. Neurochem. Res. 2008, 33:285-291.
217. Shimada S., Inagaki S., Kubota Y., Ogawa N., Shibasaki T., Takagi H. Coexistence of peptides (corticotropin releasing factor/neurotensin and substance P/somatostatin) in the bed nucleus of the stria terminalis and central amygdaloid nucleus of the rat. Neuroscience 1989, 30:377-383.
218. Siggins G.R., Roberto M., Nie Z. The tipsy terminal: presynaptic effects of ethanol. Pharmacol. Ther. 2005, 107:80-98.
219. Sills G.J. The mechanisms of action of gabapentin and pregabalin. Curr. Opin. Pharmacol. 2006, 6:108-113.
220. Skofitsch G., Jacobowitz D.M. Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides 1985, 6:509-546.
221. Smothers C.T., Mrotek J.J., Lovinger D.M. Chronic ethanol exposure leads to a selective enhancement of N-methyl-d-aspartate receptor function in cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 1997, 283:1214-1222.
222. Sommer W.H., Rimondini R., Hansson A.C., Hipskind P.A., Gehlert D.R., Barr C.S., Heilig M.A. Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala Crhr1 expression following a history of dependence. Biol. Psychiatry 2008, 63:139-145.
223. Sparta D.R., Fee J.R., Hayes D.M., Knapp D.J., MacNeil D.J., Thiele T.E. Peripheral and central administration of a selective neuropeptide Y Y1 receptor antagonist suppresses ethanol intake by C57BL/6J mice. Alcohol. Clin. Exp. Res. 2004, 28:1324-1330.
224. Stanley B.G., Leibowitz S.F. Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc. Natl. Acad. Sci. U.S.A. 1985, 82:3940-3943.
225. Sun N., Cassell M.D. Intrinsic GABAergic neurons in the rat central extended amygdala. J. Comp. Neurol. 1993, 15:381-404.
226. Sun N., Roberts L., Cassell M.D. Rat central amygdaloid nucleus projections to the bed nucleus of the stria terminalis. Brain Res. Bull. 1991, 27:651-662.
227. Thiele T.E., Koh M.T., Pedrazzini T. Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J. Neurosci. 2002, 22:RC208.
228. Ticku M.K., Burch T. Alterations in gamma-aminobutyric acid receptor sensitivity following acute and chronic ethanol treatments. J. Neurochem. 1980, 34:417-423.
229. Tye K.M., Prakash R., Kim S.Y., Fenno L.E., Grosenick L., Zarabi H., Thompson K.R., Gradinaru V., Ramakrishnan C., Deisseroth K. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 2011, 471:358-362.
230. Umhau J.C., Momenan R., Schwandt M.L., Singley E., Lifshitz M., Doty L., et al. Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study. Arch. Gen. Psychiatry 2010, 67:1069-1077.
231. Valdez G.R., Koob G.F. Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol. Biochem. Behav. 2004, 79:671-689.
232. Valdez G.R., Platt D.M., Rowlett J.K., Rüedi-Bettschen D., Spealman R.D. Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms. J. Pharmacol. Exp. Ther. 2007, 323:525-533.
233. Valdez G.R., Roberts A.J., Chan K., Davis H., Brennan M., Zorrilla E.P., Koob G.F. Increased ethanol self-administration and anxiety-like behavior during acute withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol. Clin. Exp. Res. 2002, 26:1494-1501.
234. Valdez G.R., Zorrilla E.P., Roberts A.J., Koob G.F. Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol 2003, 29:55-60.
235. Veening J.G., Swanson L.W., Sawchenko P.E. The organization of projections from the central nucleus of the amygdala to brainstem sites involved in central autonomic regulation: a combined retrograde transport-immunohistochemical study. Brain Res. 1984, 303:337-357.
236. Veinante P., Freund-Mercier M.J. Intrinsic and extrinsic connections of the rat central extended amygdala: an in vivo electrophysiological study of the central amygdaloid nucleus. Brain Res. 1998, 794:188-198.
237. Walker B.M., Koob G.F. The γ-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcohol. Clin. Exp. Res. 2008, 31:11-18.
238. Walker B.M., Zorrilla E.P., Koob G.F. Systemic κ-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addict. Biol. 2010, 16:116-119.
239. Wan F.J., Berton F., Madamba S.G., Francesconi W., Siggins G.R. Low ethanol concentrations enhance GABAergic inhibitory postsynaptic potentials in hippocampal pyramidal neurons only after block of GABAB receptors. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:5049-5054.
240. Wang J., Carnicella S., Phamluong K., Jeanblanc J., Ronesi J.A., Chaudhri N., Janak P.H., Lovinger D.M., Ron D. Ethanol induces long-term facilitation of NR2B-NMDA receptor activity in the dorsal striatum: implications for alcohol drinking behavior. J. Neurosci. 2007, 27:3593-3602.
241. Wang L., Liu H., Harvey-White J., Zimmer A., Kunos G. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:1393-1398.
242. Watanabe T., Nakagawa T., Yamamoto R., Maeda A., Minami M., Satoh M. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn. J. Pharmacol. 2002, 88:399-406.
243. Waters S.M., Krause J.E. Distribution of galanin-1, -2 and -3 receptor messenger RNAs in central and peripheral rat tissues. Neuroscience 2000, 95:265-271.
244. Weiner J.L., Valenzuela C.F. Ethanol modulation of GABAergic transmission: the view from the slice. Pharmacol. Ther. 2006, 111:533-554.
245. Wee S., Koob G.F. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology 2010, 210:121-135.
246. Weiss J.M., Boss-Williams K.A., Moore J.P., Demetrikopoulos M.K., Ritchie J.C., West C.H. Testing the hypothesis that locus coeruleus hyperactivity produces depression-related changes via galanin. Neuropeptides 2005, 39:281-287.
247. Weller K.L., Smith D.A. Afferent connections to the bed nucleus of the stria terminalis. Brain Res. 1982, 232:255-270.
248. Wirkner K., Eberts C., Poelchen W., Allgaier C., Illes P. Mechanism of inhibition by ethanol of NMDA and AMPA receptor channel functions in cultured rat cortical neurons. Naunyn Schmiedebergs Arch. Pharmacol. 2000, 362:568-576.
249. World Health Organization (2007) International Classification of Diseases. 10th revision. Retrieved from http://apps.who.int/classifications/apps/icd/icd10online/.
250. Wu L.G., Saggau P. Presynaptic calcium is increased during normal synaptic transmission and paired-pulse facilitation, but not in long-term potentiation in area CA1 of hippocampus. J. Neurosci. 1994, 14:645-654.
251. Xuei X., Dick D., Flury-Wetherill L., Tian H.-J., Agrawal A., Bierut L., et al. Association of the κ-opioid system with alcohol dependence. Mol. Psychiatry 2006, 11:1016-1024.
252. Zarrindast M.R., Sarahroodi S., Arzi A., Khodayar M.J., Taheri-Shalmani S., Rezayof A. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system. Behav. Pharmacol. 2008, 19:716-723.
253. Zhao Y., Dayas C.V., Aujla H., Baptista M.A., Martin-Fardon R., Weiss F. Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos expression in the hippocampus and amygdala. J. Neurosci. 2006, 26:9967-9974.
254. Zhao Y., Weiss F., Zorrilla E.P. Remission and resurgence of anxiety-like behavior across protracted withdrawal stages in ethanol-dependent rats. Alcohol. Clin. Exp. Res. 2007, 31:1505-1515.
255. Zhu P.J., Lovinger D.M. Ethanol potentiates GABAergic synaptic transmission in a postsynaptic neuron/synaptic bouton preparation from basolateral amygdala. J. Neurophysiol. 2006, 96:433-441.
256. Zorrilla E.P., Valdez G.R., Weiss F. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology 2001, 158:374-381.
257. Zorrilla E.P., Zhao Y., Koob G.F. Anti-CRF. Encyclopedia of Stress 2007, vol. 1 A-E:206-214. Elsevier, Amsterdam.